Firazyr
In the US, Firazyr (icatibant systemic) is a member of the drug class miscellaneous cardiovascular agents and is used to treat Hereditary Angioedema.
US matches:
UK matches:
Ingredient matches for Firazyr
Icatibant is reported as an ingredient of Firazyr in the following countries:
- Denmark
- Greece
- Luxembourg
- Norway
Icatibant acetate (a derivative of Icatibant) is reported as an ingredient of Firazyr in the following countries:
- Austria
- Belgium
- Finland
- France
- Germany
- Israel
- Italy
- Lithuania
- Spain
- Sweden
- Switzerland
- United Kingdom
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
